Gynaecomastia with hypergonadotrophic hypogonadism and Leydig cell insuffiency in recipients of high-dose chemotherapy or chemo-radiotherapy

Bone Marrow Transplantation

Volumn 28, Issue 12, 2001, Pages 1141-1144

  Harris, E ^a   Mahendra, P ^a   McGarrigle, H H ^a   Linch, D C ^a   Chatterjee, R ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Chemo radiotherapy; Gynaecomastia; High dose chemotherapy; Hypergonadotrophic hypogonadism; Hypogonadism; Leydig cell insufficiency

Indexed keywords

ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; CARMUSTINE; CIMETIDINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; MELPHALAN; MYELOABLATIVE AGENT; RANITIDINE; STEROID; TESTOSTERONE;

ADULT; ALLOGRAFT; ANXIETY; ARTICLE; AUTOGRAFT; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; ENDOCRINE DISEASE; ENDOCRINE FUNCTION TEST; ERECTILE DYSFUNCTION; GYNECOMASTIA; HORMONE SUBSTITUTION; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; HYPERPROLACTINEMIA; IMMUNOSUPPRESSIVE TREATMENT; LEYDIG CELL; LIBIDO; MALE; PRIORITY JOURNAL; RECIPIENT; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

ADULT; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; DEHYDROEPIANDROSTERONE; GONADOTROPINS; GYNECOMASTIA; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; LEYDIG CELLS; MALE; MIDDLE AGED; RADIOTHERAPY; RETROSPECTIVE STUDIES;

EID: 0035691947     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703302     Document Type: Article

References (25)

1. Gonadal damage from chemotherapy and radiotherapy
2. Gonadal damage and effects on fertility after bone marrow transplantation
3. Partial hypopituitarism following TBI in adult patients with haematological malignancy
4. Hypopituitarism following external radiotherapy for pituitary tumours in adults
5. Patterns of Leydig cell insufficiency in adult males, following bone marrow transplantation for haematological malignancies
6. Male breast at autopsy
7. Gynaecomastia as a physical finding in normal men
8. Cavernosal arterial insufficiency and erectile dysfunction in recipients of high dose chemotherapy and total body irradiation for multiple myeloma
9. Classification and surgical correction of gynaecomastia
10. Diurnal cycles in plasma FSH, testosterone and cortisol in men
11. Circadian rhythm of serum testosterone, and its relation to sleep: Comparison with the variation in serum luteinising hormone, prolactin, and cortisol in normal men
12. Comparison of estimates of gonadotrophin levels by isolated blood samples, integrated blood concentrations and timed urinary fractions
13. Germ cell failure and Leydig cell insufficiency in post-pubertal males after autolagous bone marrow transplantation with BEAM for lymphoma
14. Gynaecomastia
15. The effects of drugs on endocrine system
16. Gynaecomastia as a complication of chemotherapy for testicular germ cell tumours
17. Gynaecomastia as a presenting feature of thyrotoxicosis
18. The effect of cimertidine on the oxidative metabolism of oestradiol
19. The acute and long term effect of the H2-receptor antagonists cimetidine and ranitidine on the pituitary gonadal axis in men
20. Dehydroepiandrosterone in the treatment of erectile dysfunction: A prospective, double blind, randomized, placebo-controlled study
21. Recent advances in clinical/molecular andrology
22. Androgens and penile erection: Evidence for a direct relationship between free testosterone and cavernous vasodilatation in men with erectile dysfunction
23. Lack of sexual activity from erectile dysfunction is associated with a reversible reduction in serum testosterone
24. Technical refinements in the surgical treatment of gynaecomastia
25. Surgical correction of gynaecomastia: A new approach